FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...

Looking for a reliable way to lose weight?? Meet Mounjaro UAE, the latest injectable medication that’s making waves among ...

The company warned that compounded versions of tirzepatide are not beholden to ... billion manufacturing scale-up campaign, all doses of Mounjaro and Zepbound have been available in the U.S ...

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

finding once again that the supply of tirzepatide currently meets or exceeds demand. Both Mounjaro and Zepbound are exclusive to Eli Lilly, but compounding pharmacies are permitted to make and ...

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...

Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

Eli Lilly intervenes in lawsuit to defend FDA's shortage determination of tirzepatide injections, branded as Mounjaro and Zepbound. FDA allows compounding of tirzepatide injections until February ...

Lilly seeks to protect interests in compounded drug case ... loss drug Zepbound and diabetes medicine Mounjaro, which have the same active ingredient, tirzepatide. The FDA declined to comment.